Close Menu
    Facebook X (Twitter) Instagram Pinterest YouTube LinkedIn TikTok
    TopBuzzMagazine.com
    Facebook X (Twitter) Instagram Pinterest YouTube LinkedIn TikTok
    • Home
    • Movies
    • Television
    • Music
    • Fashion
    • Books
    • Science
    • Technology
    • Cover Story
    • Contact
      • About
      • Amazon Disclaimer
      • Terms and Conditions
      • Privacy Policy
      • DMCA / Copyrights Disclaimer
    TopBuzzMagazine.com
    Home»Technology»Making Science More Open Is Good for Research—but Bad for
    Technology

    Making Science More Open Is Good for Research—but Bad for

    By AdminMay 10, 2022
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    Of course, just because research is published in a journal instead of a preprint server doesn’t mean it’s inherently risk-free. But it does mean that any glaring dangers are more likely to be picked up in the reviewing process. “The key difference, really, between journals and the preprint server is the level of depth that the review is going into, and the journal publication process may be more likely to identify risks,” says Smith. 

    The risks of open publishing don’t stop at biological research. In the AI field a similar movement toward openly sharing code and data means there’s potential for misuse. In November 2019, OpenAI announced it would not be openly publishing in full its new language model GPT-2, which can independently generate text and answer questions, for fear of “malicious applications of the technology”—meaning its potential to spread fake news and disinformation. Instead, OpenAI would publish a much smaller version of the model for researchers to tinker with, a decision that drew criticism at the time. (It went on to publish the full model in November of that year.) Its successor, GPT-3, published in 2020, was found to be capable of writing child porn.

    Two of the biggest preprint servers, medRxiv, founded in 2019 to publish medical research, and bioRxiv, founded in 2013 for biological research, publicly state on their websites that they check that “dual-use research of concern” is not being posted on their sites. “All manuscripts are screened on submission for plagiarism, non-scientific content, inappropriate article types, and material that could potentially endanger the health of individual patients or the public,” a statement on medRxiv reads. “The latter may include, but is not limited to, studies describing dual-use research and work that challenges or could compromise accepted public health measures and advice regarding infectious disease transmission, immunization, and therapy.”

    From bioRxiv’s outset, biosecurity risks were always a concern, says Richard Sever, one of bioRxiv’s cofounders and assistant director of Cold Spring Harbor Laboratory Press. (Sever was a peer reviewer of Smith and Sandbrink’s paper.) He jokes that in the early days of arXiv, a preprint server for the physical sciences launched in 1991, there were worries about nuclear weapons; with bioRxiv today the worries are about bioweapons. 

    Sever estimates bioRxiv and medRxiv get about 200 submissions a day, and every one of them is looked at by more than one pair of eyes. They get “a lot of crap” that is immediately tossed out, but the rest of the submissions go into a pool to be screened by practicing scientists. If someone in that initial screening process flags a paper that may pose a concern, it gets passed up the chain to be considered by the management team before a final call is made. “We always try to err on the side of caution,” Sever says. So far nothing has been posted that turned out to be dangerous, he reckons. 

    A few papers have been turned away over the years because the team thought they fell into the category of dual-use research of concern. When the pandemic arrived, the issue became all the more urgent. The two servers published more than 15,000 preprints on Covid-19 by April 2021. It became an internal wrangle: Do the high life-or-death stakes of a pandemic mean they are morally required to publish papers on what they call “pathogens of pandemic potential”—like Sars-CoV-2—which they might have traditionally turned away in the past? “The risk-benefit calculation changes,” Sever says. 

    Read The Full Article Here

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    A look at some US energy companies linked to AI infrastructure, such as Sam Altman-backed Oklo, whose stocks have soared despite having little to no revenue (Jinjoo Lee/Wall Street Journal)

    October 19, 2025

    The New Power of Far-Right Influencers

    October 18, 2025

    Inside Hyperliquid, a booming DEX for perpetual crypto futures still controlled by a small insider group, raising questions about how decentralized it really is (Muyao Shen/Bloomberg)

    October 18, 2025

    Some of Our Favorite Noise-Canceling Headphones Are $100 Off if You Act Fast

    October 17, 2025

    Reddit announces that it is expanding its Google Gemini-powered search experience to five new languages: French, German, Spanish, Italian, and Portuguese (Ivan Mehta/TechCrunch)

    October 17, 2025

    Why the F5 Hack Created an ‘Imminent Threat’ for Thousands of Networks

    October 16, 2025
    popular posts

    Will Leet Releases New Music

    Bloomer Shorts Are Trending — Here’s Where to Buy Them

    Transforming the Trajectory of Lung Cancer [Sponsored]

    Hot 100 First-Timers: Steve Lacy Makes Good First Impression With

    RBI’s Views Might Have Delayed Crypto Bill: Deputy Governor Michael

    The Funniest Episodes of Drama TV Shows

    What Your Favorite Musicians Wore to the 2023 Met Gala

    Categories
    • Books (3,479)
    • Cover Story (8)
    • Events (20)
    • Fashion (2,566)
    • Interviews (47)
    • Movies (2,779)
    • Music (3,064)
    • News (162)
    • Politics (6)
    • Science (4,630)
    • Technology (2,774)
    • Television (3,504)
    • Uncategorized (932)
    Archives
    Facebook X (Twitter) Instagram Pinterest YouTube Reddit TikTok
    © 2025 Top Buzz Magazine. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Do not sell my personal information.
    Cookie SettingsAccept
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT